Studies with PYY agonists administered intravenously have shown reduction in food intake with increased satiety [92, 93], however, a nasal PYY agonist showed minimal efficacy with poor tolerability [94]
I'm just wondering what evidence you have for this
According to the Department of Justice, Tailor Made had to forfeit over $1.7 million in revenue from selling BPC-157 and a slew of other illicit compounds
Injections, however, deliver a potent, concentrated dose directly into the subdermal tissue where it can immediately signal your cells to begin the repair process, making it a much more effective approach for significant results
AOD9604 is classified under the Peptide Hormones and Related Substances category by WADA, making it a banned compound in all forms of competitive athletics. World AntiDoping Agency Disclaimer The content in this article is provided for educational and informational purposes only